DS
LHDX

David Shaw’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

David Shaw’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,866
Closed -$26K – 5712
2022
Q2 		$26K Sell
13,866
-5,782
-29% -$14.1K ﹤0.01% 4965
2022
Q1 		$70K Sell
19,648
-54,917
-74% -$270K ﹤0.01% 5067
2021
Q4 		$642K Buy
+74,565
New +$474K ﹤0.01% 4257

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return

David Shaw's LHDX Position: Q3 2022 in Review

David Shaw sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 13,866 shares — an estimated $26K sold.

David Shaw first reported a position in LHDX in Q4 2021 and held it in 3 quarters. The position peaked at $642K in Q4 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • David Shaw reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 13,866 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $26K.
  • David Shaw first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • David Shaw's Lucira Health, Inc. Common Stock position peaked at $642K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.